Kevin Strange

This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (July 2017) (Learn how and when to remove this template message) The lead section of this article may need to be rewritten. Use the lead layout guide to ensure the section follows Wikipedia's norms and is inclusive of all essential details. (July 2017) (Learn how and when to remove this template message) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help by replacing them with more appropriate citations to reliable, independent, third-party sources. (July 2017) (Learn how and when to remove this template message) This article's tone or style may not reflect the encyclopedic tone used on Wikipedia. See Wikipedia's guide to writing better articles for suggestions. (July 2017) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Kevin Strange became the first president and full-time director of the MDI Biological Laboratory in July 2009 after a career as an NIH-funded biomedical scientist and administrator at Harvard Medical School and Vanderbilt University School of Medicine. As president, Strange is refocusing the MDI Biological Laboratory's research program and recruiting multidisciplinary scientists to understand the genetic mechanisms of tissue repair, regeneration, and aging. In 2013, three years after establishing this new research focus, the MDI Biological Laboratory was recognized by the National Institutes of Health as a center of research excellence in regenerative and aging biology and medicine.^[1]

Before arriving in Maine, Strange was associate professor at Harvard Medical School and director of the critical care research laboratories at Children's Hospital in Boston. In 1997, he moved to Vanderbilt University School of Medicine, where he was the John C. Parker Professor and director of research in the department of anesthesiology.^[1]

Strange is an expert in the field of cellular stress biology. His research focuses on how proteins are damaged by environmental stressors and how cells detect, degrade, and repair these damaged proteins. This work furthers understanding of degenerative changes that occur as humans age. Strange has published over 125 original papers, review articles, and books. He holds bachelor's and master's degrees from the University of California at Davis and received his doctorate from the University of British Columbia.^[1]

In 2013, Strange and assistant professor Voot Yin, Ph.D., founded the MDI Biological Laboratory's first spinout company, , Inc., to accelerate the testing and development of a novel drug for patients with heart disease.^[2] That year, the magazine Mainebiz named Strange one Maine's ten most “innovative business people” who “hold tremendous promise for the state” and its future economy.^[3]

In 2018, Kevin Strange stepped down as president of MDI Biological Laboratory, and Hermann Haller assumed the post.^[4] In 2020, Kevin Strange left MDI Biological Laboratory, and returned to Vanderbilt as Professor of Anesthesiology.^[5] His CV has no mention of ever working at MDI Biological Laboratory.^[6]

References[]

External links[]

• [1]
• [2]